The impact of semaglutide on fusion rates following posterior lumbar fusion surgery in patients with type 2 diabetes
{{output}}
Background: Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used in managing type 2 diabetes mellitus (T2DM), has demonstrated cardiovascular and glycemic benefits. However, its influence on surgical outcomes, par... ...
